Immunogenicity, Effectiveness, and Safety of Trivalent Inactivated Influenza Split Vaccine in Patients with Inflammatory Joint Diseases Receiving Modern Antirheumatic Therapy
According to the currently available data from large cohort studies, patients with immuno-inflammatory rheumatic diseases (IIRDs) are at increased risk of infectious complications, including influenza, compared to the general population. Vaccinations are a critical component of their care. However,...
Saved in:
Main Authors: | M. M. Baranova, N. V. Muravyeva, B. S. Belov, M. E. Diatroptov, D. V. Bukhanova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
LLC "Publishing House OKI"
2024-06-01
|
Series: | Антибиотики и Химиотерапия |
Subjects: | |
Online Access: | https://www.antibiotics-chemotherapy.ru/jour/article/view/1129 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunogenicity, efficacy and safety of the three-valent inactivated influenza split vaccine in patients with ankylosing spondylitis and psoriatic arthritis
by: M. M. Baranova, et al.
Published: (2024-06-01) -
Evaluation of the possibility of axial psoriatic arthritis patients meet classification criteria for axial spondyloarthritis and ankylosing spondylitis
by: E. E. Gubar, et al.
Published: (2023-08-01) -
Diagnosis of spondyloarthritis: should we need new criteria?
by: I. Z. Gaidukova, et al.
Published: (2015-03-01) -
«TREAT-TO-TARGET» (T2T) STRATEGY IN SPONDYLOARTHRITIS
by: Sh. F. Erdes
Published: (2014-06-01) -
Comorbid Infections in Spondyloarthritis: the Current State of the Problem
by: M. M. Baranova, et al.
Published: (2025-04-01)